IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,090,241 | +9.1% | 68,127 | -1.4% | 0.01% | 0.0% |
| Q2 2023 | $2,833,655 | -59.8% | 69,063 | -60.9% | 0.01% | -81.2% |
| Q2 2021 | $7,054,000 | +12.1% | 176,820 | +58.9% | 0.03% | -5.9% |
| Q4 2020 | $6,291,000 | +133.2% | 111,269 | +95.7% | 0.03% | +100.0% |
| Q3 2020 | $2,698,000 | +4323.0% | 56,862 | +5496.7% | 0.02% | – |
| Q4 2019 | $61,000 | +79.4% | 1,016 | +81.1% | 0.00% | – |
| Q3 2019 | $34,000 | +325.0% | 561 | +523.3% | 0.00% | – |
| Q1 2019 | $8,000 | -99.1% | 90 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $922,000 | -88.4% | 17,878 | -86.1% | 0.00% | -94.7% |
| Q4 2015 | $7,947,000 | – | 128,328 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |